|
1
|
Wild CP, Weiderpass E and Stewart BW:
World Cancer Report: Cancer research for cancer prevention. Lyon,
France: International Agency for Research on Cancer; 2020
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alberg AJ, Ford JG and Samet JM; American
College of Chest Physicians, : Epidemiology of lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132 (Suppl 3):29S–55S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tiseo M, Bordi P, Bortesi B, Boni L, Boni
C, Baldini E, Grossi F, Recchia F, Zanelli F, Fontanini G, et al:
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and
predictive factors in advanced NSCLC treated with or without
cisplatin. Br J Cancer. 108:1695–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sallum LF, Andrade L, Bastos Eloy da Costa
L, Ramalho S, Ferracini AC, Natal RA, Brito ABC, Sarian LO and
Derchain S: BRCA1, Ki67, and β-catenin immunoexpression is not
related to differentiation, platinum response, or prognosis in
women with low- and high-grade serous ovarian carcinoma. Int J
Gynecol Cancer. 28:437–447. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huyton T, Bates PA, Zhang X, Sternberg MJ
and Freemont PS: The BRCA1 C-terminal domain: Structure and
function. Mutat Res. 460:319–332. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fairley S, Lowy-Gallego E, Perry E and
Flicek P: The international genome sample resource (IGSR)
collection of open human genomic variation resources. Nucleic Acids
Res. 48(D1): D941–D947. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
NCBI. Gene Database. RefSeq, .
2020.https://www.ncbi.nlm.nih.gov/gene/672
|
|
9
|
Morris JR, Pangon L, Boutell C, Katagiri
T, Keep NH and Solomon E: Genetic analysis of BRCA1 ubiquitin
ligase activity and its relationship to breast cancer
susceptibility. Hum Mol Genet. 15:599–606. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moynahan ME and Jasin M: Mitotic
homologous recombination maintains genomic stability and suppresses
tumorigenesis. Nat Rev Mol Cell Biol. 11:196–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miki Y, Swensen J, Shattuck-Eidens D,
Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM,
Ding W, et al: A strong candidate for the breast and ovarian cancer
susceptibility gene BRCA1. Science. 266:66–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clark SL, Rodriguez AM, Snyder RR, Hankins
GD and Boehning D: Structure-function of the tumor suppressor
BRCA1. Comput Struct Biotechnol J. 1:e2012040052012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Medema RH and Macůrek L: Checkpoint
control and cancer. Oncogene. 31:2601–2613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Symington LS and Gautier J: Double-strand
break end resection and repair pathway choice. Annu Rev Genet.
45:247–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scully R and Livingston DM: In search of
the tumour-suppressor functions of BRCA1 and BRCA2. Nature.
408:429–432. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Venkitaraman AR: Cancer susceptibility and
the functions of BRCA1 and BRCA2. Cell. 108:171–182. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nicoloso MS, Sun H, Spizzo R, Kim H,
Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L,
et al: Single-nucleotide polymorphisms inside microRNA target sites
influence tumor susceptibility. Cancer Res. 70:2789–2798. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The eighth edition lung cancer stage classification. Chest.
151:193–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
World Health Organization, . Guidelines
for controlling and monitoring the tobacco epidemic. Geneva,
Switzerland: WHO; 1998
|
|
21
|
Wang HT, Gao Y, Zhao YX, Yu H, Wang TL,
Bai L, Chen YZ, Zhang HB, Zhou BS, Qu YL, et al: PARP-1 rs3219073
polymorphism may contribute to susceptibility to lung cancer. Genet
Test Mol Biomarkers. 18:736–740. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yurgelun MB, Kulke MH, Fuchs CS, Allen BA,
Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, et
al: Cancer susceptibility gene mutations in individuals with
colorectal cancer. J Clin Oncol. 35:1086–1095. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grynberg M, Raad J, Comtet M, Vinolas C,
Cédrin-Durnerin I and Sonigo C: Fertility preservation in
BRCA-mutated women: When and how? Future Oncol. 14:483–490. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kennedy RD, Quinn JE, Johnston PG and
Harkin DP: BRCA1: Mechanisms of inactivation and implications for
management of patients. Lancet. 360:1007–1014. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB,
Liu W, Qi Q, Lu N, Tao L, Wang XT, et al: Isolation and
characterization of cancer stem like cells in human glioblastoma
cell lines. Cancer Lett. 279:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu J, Lu LY and Yu X: The role of BRCA1 in
DNA damage response. Protein Cell. 1:117–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chatterjee N and Walker GC: Mechanisms of
DNA damage, repair, and mutagenesis. Environ Mol Mutagen.
58:235–263. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moynahan ME, Cui TY and Jasin M:
Homology-directed dna repair, mitomycin-c resistance, and
chromosome stability is restored with correction of a Brca1
mutation. Cancer Res. 61:4842–4850. 2001.PubMed/NCBI
|
|
31
|
Wu HC, Delgado-Cruzata L, Machella N, Wang
Q, Santella RM and Terry MB: DNA double-strand break repair
genotype and phenotype and breast cancer risk within sisters from
the New York site of the breast cancer family registry (BCFR).
Cancer Causes Control. 24:2157–2168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang JS, Yeh RF, Wiencke JK, Wiemels JL,
Smirnov I, Pico AR, Tihan T, Patoka J, Miike R, Sison JD, et al:
Pathway analysis of single-nucleotide polymorphisms potentially
associated with glioblastoma multiforme susceptibility using random
forests. Cancer Epidemiol Biomarkers Prev. 17:1368–1373. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li D, Wang Q, Liu C, Duan H, Zeng X, Zhang
B, Li X, Zhao J, Tang S, Li Z, et al: Aberrant expression of
miR-638 contributes to benzo(a)pyrene-induced human cell
transformation. Toxicol Sci. 125:382–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sirisena ND, Adeyemo A, Kuruppu AI,
Samaranayake N and Dissanayake VHW: Genetic variants associated
with clinicopathological profiles in sporadic breast cancer in Sri
Lankan women. J Breast Cancer. 21:165–172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang M, Du X, Zhang F and Yuan S:
Association between BRCA1 polymorphisms rs799917 and rs1799966 and
breast cancer risk: A meta-analysis. J Int Med Res. 47:1409–1416.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ghafouri-Fard S, Dianatpour A and
Faramarzi S: Meta-analysis of BRCA1 polymorphisms and breast cancer
susceptibility. Klin Onkol. 31:330–338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma J, Liu M, Zhang X and BuRi G:
Correlation anslysis of sporadic breast cancer and BRCA1 gene
plymorphisms in the Han nationality and the Mongol nationality of
inner Mongolia region. Zhonghua Yi Xue Za Zhi. 95:3746–3749.
2015.(In Chinese). PubMed/NCBI
|
|
38
|
Qin TT, Chen T, Zhang Q, Du HN, Shu YQ,
Luo K and Zhu LJ: Association between BRCA1 rs799917 polymorphism
and breast cancer risk: A meta-analysis of 19,878 subjects. Biomed
Pharmacother. 68:905–910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou X, Han S, Wang S, Chen X, Dong J, Shi
X, Xia Y, Wang X, Hu Z and Shen H: Polymorphisms in HPV E6/E7
protein interacted genes and risk of cervical cancer in Chinese
women: A case-control analysis. Gynecol Oncol. 114:327–331. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang X, Wei J, Zhou L, Zhou C, Shi J,
Yuan Q, Yang M and Lin D: A functional BRCA1 coding sequence
genetic variant contributes to risk of esophageal squamous cell
carcinoma. Carcinogenesis. 34:2309–2313. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee SY, Kang HG, Yoo SS, Kang YR, Choi YY,
Lee WK, Choi JE, Jeon HS, Shin KM, Oh IJ, et al: Polymorphisms in
DNA repair and apoptosis-related genes and clinical outcomes of
patients with non-small cell lung cancer treated with first-line
paclitaxel-cisplatin chemotherapy. Lung Cancer. 82:330–339. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang K, Xu L, Pan L, Xu K and Li G: The
functional BRCA1 rs799917 genetic polymorphism is associated with
gastric cancer risk in a Chinese Han population. Tumour Biol.
36:393–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu GP, Zhao Q, Wang D, Xie WY, Zhang LJ,
Zhou H, Chen SZ and Wu LF: The association between BRCA1 gene
polymorphism and cancer risk: A meta-analysis. Oncotarget.
9:8681–8694. 2018. View Article : Google Scholar : PubMed/NCBI
|
